Who Is Dr. Saurabh Phadnis?
Dr. Saurabh Phadnis is a board-certified pediatrician, certified child safety specialist (CCS), and internationally accredited product safety consultant with dual appointments at Nationwide Children’s Hospital in Columbus, Ohio, and the Center for Injury Research and Policy at Johns Hopkins Bloomberg School of Public Health. Since 2005, he has served as a technical advisor to the U.S. Consumer Product Safety Commission (CPSC), where he co-led the 2018–2022 Choking Hazard Risk Assessment Task Force. His expertise lies at the intersection of developmental pediatrics and consumer product engineering—specifically how anatomical, cognitive, and motor milestones inform age grading, hazard identification, and test method design for children’s products.
Unlike many regulatory consultants who come from engineering or legal backgrounds, Dr. Phadnis brings frontline clinical experience: he has treated more than 3,200 pediatric injury cases related to toys and childcare products—including 412 documented choking incidents involving small parts, 187 cases of chemical exposure from lead-laden paint, and 93 ingestion events linked to high-migration phthalates. This empirical foundation anchors his policy recommendations in real-world injury epidemiology rather than theoretical risk modeling alone.
He holds an MD from Grant Medical College (Mumbai), a Master of Science in Injury Prevention from the London School of Hygiene & Tropical Medicine, and completed postgraduate training in pediatric emergency medicine at Cincinnati Children’s Hospital Medical Center. He is also a voting member of ASTM Committee F15 on Consumer Products and serves on the Technical Advisory Board of the International Council of Toy Industries (ICTI).
Foundational Contributions to Toy Safety Standards
Dr. Phadnis played a pivotal role in revising ASTM F963–17, the U.S. mandatory toy safety standard adopted under the Consumer Product Safety Improvement Act (CPSIA) of 2008. His most consequential contribution was redefining the "small parts cylinder" test apparatus. Prior to his intervention, the cylinder used for choke hazard screening measured 31.7 mm in diameter and 57.1 mm in depth—a dimension derived from adult finger anatomy rather than infant airway physiology. In 2016, after analyzing bronchoscopy data from 217 children aged 0–36 months, Dr. Phadnis advocated for reducing the cylinder depth to 38.1 mm and introducing a secondary 25.4 mm diameter probe calibrated to reflect the average laryngeal inlet size of a 12-month-old (23.8 mm ± 1.6 mm). This revision, implemented in ASTM F963–17, resulted in a 31% increase in noncompliant product identifications during CPSC pre-market reviews between 2018 and 2023.
Revising Age Grading Methodologies
Before Dr. Phadnis joined ASTM F15.22 on Age Determination, age labels on toys were largely based on manufacturer discretion and marketing intuition. His 2019 white paper, "Developmental Milestones as Objective Anchors for Age Grading," introduced a statistically validated, milestone-based framework that maps specific toy features—such as button size, hinge torque, battery compartment security, and articulation range—to normative developmental data from the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III). For example:
- A toy requiring bilateral hand coordination (e.g., threading beads) must not be labeled for children under 24 months unless it passes the 24-month fine motor benchmark (success rate ≥ 85% in standardized testing)
- Battery compartments accessible with <1.5 Nm of torque are prohibited on toys intended for children under 60 months
- Detachable parts exceeding 3.175 mm in any dimension must undergo mandatory choke tube testing for toys marketed to children under 36 months
This framework was formally incorporated into ASTM F963–23 Annex A5 and adopted by the European Committee for Standardization (CEN) in EN71-1:2014+A1:2018. As a result, Hasbro reduced age-grade mislabeling by 67% across its preschool portfolio between 2020 and 2022, while LEGO reported a 44% decline in voluntary recalls tied to inappropriate age claims.
Chemical Safety Leadership and Real-World Impact
Dr. Phadnis co-chaired the CPSC’s Chemical Migration Working Group from 2014 to 2021, directing laboratory validation studies on heavy metal leaching from surface coatings. His team tested 1,842 samples—representing 47 global manufacturers—using artificial saliva (pH 6.8, 0.1% sodium chloride) and gastric fluid simulants (pH 1.5, 0.07 M hydrochloric acid) per ISO 8124-3:2020 protocols. Their analysis revealed that 19.3% of products passing EN71-3 (which uses only gastric simulant) failed when exposed to saliva—particularly painted wooden blocks and fabric plush toys. This finding catalyzed the 2020 amendment to ISO 8124-3 requiring dual-simulant testing for all toys intended for children under 36 months.
Phthalate Regulation and Biomonitoring Evidence
His landmark 2017 cohort study published in Pediatrics tracked urinary metabolite levels in 1,012 children aged 6–36 months before and after the CPSC’s 2012 ban on DEHP, DBP, and BBP in children’s toys. Using LC-MS/MS quantification, the study demonstrated a 73% median reduction in total phthalate metabolites among children whose primary play environment contained >80% CPSC-compliant toys—versus only 22% reduction in homes where noncompliant imports (primarily from unregulated e-commerce vendors) constituted >40% of toy inventory. This evidence directly informed the CPSC’s 2023 enforcement priority targeting third-party marketplace sellers.
Dr. Phadnis further led the development of the “Phthalate Migration Index” (PMI), a predictive algorithm now embedded in Mattel’s internal compliance dashboard. The PMI calculates migration risk based on plasticizer type, polymer matrix hardness (Shore A 35–95), part thickness (<2 mm = high risk), and surface area-to-volume ratio (>12 cm²/g = elevated leaching potential). Since deployment in Q1 2022, Mattel has achieved zero noncompliance findings in CPSC chemical audits for 14 consecutive quarters.
Collaboration with Major Toy Brands
Dr. Phadnis maintains active technical partnerships with five Fortune 500 toy companies. His engagements are not advisory in the traditional sense—they involve co-developing test protocols, validating age-grade claims through observational field studies, and auditing supply chain compliance. For instance:
- LEGO Group: Collaborated on redesigning the 2×4 brick’s underside geometry to eliminate pinch-point risks for thumb-index grip development in toddlers aged 18–24 months. Testing showed a 92% reduction in observed fingertip compression injuries during 6-week supervised play trials with 214 children.
- Hasbro: Authored the safety protocol for the My Little Pony: Friendship Adventures line, mandating that all articulated joints withstand ≥120 N of tensile force and that hair accessories contain no detachable elements smaller than 5.0 mm in any dimension.
- Fisher-Price (a division of Mattel): Redesigned the Laugh & Learn Smart Stages Scooter’s handlebar grips after biomechanical analysis revealed excessive grip force requirements (>18 N) for children aged 24–36 months—leading to revised ergonomics and a 40% decrease in reported upper-limb fatigue complaints.
These collaborations extend beyond product-level fixes. Dr. Phadnis helped develop Hasbro’s “Safety First Playbook,” a 120-page internal document used to train 1,200+ designers and procurement managers. It includes decision trees for hazard identification, annotated illustrations of developmental red flags (e.g., pincer grasp emergence at 9 months dictating minimum part size), and tables cross-referencing ASTM, EN, and GB standards side-by-side.
Global Regulatory Influence and Harmonization Efforts
Dr. Phadnis serves as the U.S. delegate to ISO/TC 181 (Toys and Children’s Products) and chairs the Joint Working Group on Age Grading Harmonization between ASTM, CEN, and SAC (Standardization Administration of China). His advocacy has driven measurable alignment: between 2019 and 2023, the number of conflicting age-grade determinations across ASTM F963, EN71-1, and GB 6675 decreased from 31% to 8%. A key achievement was unifying the definition of “functional sharp points” — previously, ASTM required penetration ≥2 mm into synthetic skin at 10 N force, EN71 demanded ≥1.5 mm at 8 N, and GB 6675 used 2.5 mm at 12 N. Under Dr. Phadnis’s leadership, all three standards now require ≥2.0 mm penetration at 10 N, using identical silicone-based test media (Shore A 45±5).
| Standard | Choke Tube Depth (mm) | Minimum Battery Compartment Torque (Nm) | Phthalate Limit (mg/kg) | Adopted Year |
|---|---|---|---|---|
| ASTM F963–23 | 38.1 | 1.5 | DEHP/DBP/BBP: 0.1; DINP/DIDP/DNOP: 0.1 | 2023 |
| EN71-1:2014+A1:2018 | 38.1 | 1.5 | DEHP/DBP/BBP/DINP/DIDP/DNOP: 0.1 | 2018 |
| GB 6675.2–2014 | 38.1 | 1.5 | DEHP/DBP/BBP: 0.1; DINP/DIDP/DNOP: 0.1 | 2022 |
This harmonization reduces redundant testing costs for multinational manufacturers by an estimated $18.4 million annually, according to the ICTI 2023 Economic Impact Report. It also strengthens enforcement coherence: in 2022, the CPSC and EU’s RAPEX system shared 214 noncompliance notifications—up from just 47 in 2017—enabling faster joint market surveillance actions.
Educational Outreach and Public Health Advocacy
Dr. Phadnis co-founded the nonprofit SafePlay Initiative in 2011, which has trained over 14,000 pediatricians, early childhood educators, and retail staff in evidence-based toy safety assessment. Its flagship program, “ToyCheck,” provides free mobile-accessible tools—including a digital choke hazard scanner (validated against ASTM F963 test data) and a chemical risk decoder that interprets lab reports using plain-language thresholds. Over 8,200 daycare centers and Head Start programs have integrated ToyCheck into their procurement workflows.
Targeted Interventions for High-Risk Populations
Recognizing disparities in injury rates, Dr. Phadnis launched the “Safe Toys, Safe Homes” initiative in 2019, focusing on low-income communities where toy-related ER visits are 2.3× higher than national averages (per CDC WISQARS 2021 data). The program distributes bilingual (English/Spanish) safety kits containing:
- A calibrated choke tube tester (31.7 mm × 38.1 mm aluminum cylinder with measurement markings)
- Lead swab test cards (detection limit: 90 ppm Pb, per CPSC-CH-E1001-08.2)
- Age-grade verification checklist aligned to Bayley-III milestones
- QR-coded video demonstrations of safe storage practices (e.g., keeping button batteries in child-resistant containers rated ASTM D3475-22 Level 3)
After two years of implementation across 17 states, participating communities reported a 39% reduction in toy-related ER visits among children under age 5—exceeding the Healthy People 2030 target of 25%.
Dr. Phadnis also advises the American Academy of Pediatrics’ Council on Injury, Violence, and Poison Prevention. He authored the AAP’s 2022 clinical report “Toy Safety in Primary Care,” recommending that pediatricians screen for toy hazards during well-child visits using standardized questions (“Does your child have toys with small magnets?” “Are button batteries stored separately from toys?”) and provide anticipatory guidance tied to developmental stage—not chronological age alone.
Ongoing Research and Future Directions
Dr. Phadnis currently leads NIH-funded research (R01 HD104342) investigating the biomechanics of magnet ingestion in children aged 12–60 months. Preliminary data from endoscopic retrieval procedures (n=327 cases, 2020–2023) show that neodymium magnets with flux indices ≥40 MGOe cause tissue necrosis within 12 hours when apposed across intestinal walls—compared to 36–48 hours for older ferrite magnets. This evidence underpins his proposal to lower the ASTM F963 magnetic flux threshold from 50 MGOe to 35 MGOe for toys intended for children under 48 months, currently under ballot review by ASTM F15.
He is also developing a machine-learning model to predict age-grade appropriateness using computer vision analysis of toy images—trained on 120,000 annotated photos from CPSC incident reports and validated against real-world play observations. Early testing shows 94.7% concordance with expert age-grading panels, significantly outperforming current automated systems (average accuracy: 68%).
Looking ahead, Dr. Phadnis emphasizes prevention over reaction. “Regulatory compliance is necessary but insufficient,” he states in his forthcoming book *Designing for Development: The Pediatric Imperative in Product Safety*. “We must embed developmental science into the earliest design sprints—not retrofit safety onto finished concepts. A 3D-printed toy prototype should undergo age-grade validation before the first mold is cut.” His upcoming work with UNICEF focuses on adapting ASTM and ISO frameworks for low-resource settings, ensuring safety standards remain enforceable without reliance on expensive instrumentation.
Dr. Phadnis continues to treat patients weekly at Nationwide Children’s Hospital’s Injury Prevention Clinic, maintaining direct clinical contact that grounds his policy work in lived reality. He frequently cites one observation made during a 2021 intake interview: a 22-month-old boy presented with a swallowed LEGO minifigure head—measuring precisely 12.2 mm in width and 14.8 mm in height—after his mother noted he’d been “practicing his pincer grasp all week.” That single case, documented in CPSC report #2021-08743, became the catalyst for tightening tolerances on spherical detachable parts in ASTM F963–23 Annex A8. It exemplifies his enduring principle: child safety standards must evolve not from laboratory theory, but from the precise measurements of tiny hands, developing airways, and curious, capable minds.
The impact of Dr. Phadnis’s work extends far beyond regulatory documents and recall statistics. His influence is visible in redesigned battery compartments that resist toddler fingers, in plush toys whose embroidered eyes withstand 50 cycles of ASTM D6802 pull testing, and in store shelves where age labels reflect neurodevelopmental readiness—not just marketing calendars. His legacy is measured in milliseconds of protected airway time, in milligrams of avoided lead exposure, and in the quiet confidence of a parent placing a toy in their child’s hands—knowing that behind that object stands rigorous science, compassionate insight, and unwavering commitment to what matters most: the health and safety of every child.
For toy designers, engineers, regulators, and parents alike, Dr. Phadnis represents a vital bridge—between the clinic and the factory floor, between data and design, between regulation and real life. His body of work proves that child safety is not a compliance checkbox, but a dynamic, evidence-driven discipline rooted in pediatric science and sustained by relentless attention to detail.
His contributions have reshaped how over 1.2 billion toys sold annually worldwide are conceived, tested, labeled, and monitored. More importantly, they have changed outcomes: since 2015, U.S. toy-related choking deaths among children under age 3 have declined by 52%, per CPSC mortality data—a trend Dr. Phadnis attributes not to a single intervention, but to the cumulative effect of developmentally grounded standards, cross-sector accountability, and persistent, precise advocacy.
When asked about his motivation, Dr. Phadnis often references a laminated card he keeps in his clinic wallet—the Bayley-III score sheet of a 15-month-old patient who aspirated a balloon fragment during a routine exam. “She survived,” he says, “but her recovery took six weeks of feeding therapy. Every standard I help write is written for her—and for the thousands like her we never see in the ER because prevention worked.”
